Literature DB >> 3022280

Requirement of multiple copies of a 21-nucleotide sequence in the U3 regions of human T-cell leukemia virus type I and type II long terminal repeats for trans-acting activation of transcription.

K Shimotohno, M Takano, T Teruuchi, M Miwa.   

Abstract

The cis-acting regulatory sequence of transcription from long terminal repeats (LTRs) of human T-cell leukemia virus type I and type II (HTLV-I and HTLV-II), which is essential for action of the virally encoded trans-acting transcriptional factor(s) designated pX(s), in HTLV-I and -II was identified. Deletion of most of the U3 region of the HTLV-I LTR resulted in loss of trans-acting transcriptional activation. However, when a tandem repeat of a 21-nucleotide sequence (GAAGGCTCTGACGTCTCCCCC) that is present in the U3 region of HTLV-I and -II LTRs was inserted into the deleted U3 region of the HTLV-I LTRs, chloramphenicol acetyltransferase activity was restored. The extent of restoration of activity was proportional to the number of copies of the sequence inserted. To test the possibility that the 21-nucleotide sequence alone is necessary for trans-activation, a sequence (AGGAACTGAAA) homologous to a type-specific viral enhancer sequence and present in the U3 region of HTLV-II LTR, but not in the same region of the HTLV-I LTR, was inserted together with the 21-nucleotide sequence into the deleted U3 region of the HTLV-I LTR. However, no significant differences of the levels of activities of those LTRs compared to the LTRs with only the 21-nucleotide sequence repeats were observed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3022280      PMCID: PMC386877          DOI: 10.1073/pnas.83.21.8112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Two elements in the bovine leukemia virus long terminal repeat that regulate gene expression.

Authors:  D Derse; J W Casey
Journal:  Science       Date:  1986-03-21       Impact factor: 47.728

2.  p27x-III and p21x-III, proteins encoded by the pX sequence of human T-cell leukemia virus type I.

Authors:  T Kiyokawa; M Seiki; S Iwashita; K Imagawa; F Shimizu; M Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

3.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

4.  Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells.

Authors:  I Miyoshi; I Kubonishi; S Yoshimoto; T Akagi; Y Ohtsuki; Y Shiraishi; K Nagata; Y Hinuma
Journal:  Nature       Date:  1981-12-24       Impact factor: 49.962

5.  The p40x of human T-cell leukemia virus type I is a trans-acting activator of viral gene transcription.

Authors:  M Seiki; J Inoue; T Takeda; A Hikikoshi; M Sato; M Yoshida
Journal:  Jpn J Cancer Res       Date:  1985-12

6.  Activation of enhancer sequences in type II human T-cell leukemia virus and bovine leukemia virus long terminal repeats by virus-associated trans-acting regulatory factors.

Authors:  C A Rosen; J G Sodroski; R Kettman; W A Haseltine
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

7.  Identification of the gene responsible for human T-cell leukaemia virus transcriptional regulation.

Authors:  A J Cann; J D Rosenblatt; W Wachsman; N P Shah; I S Chen
Journal:  Nature       Date:  1985 Dec 12-18       Impact factor: 49.962

8.  Location of cis-acting regulatory sequences in the human T-cell leukemia virus type I long terminal repeat.

Authors:  C A Rosen; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

9.  Multiple sequence motifs are involved in SV40 enhancer function.

Authors:  M Zenke; T Grundström; H Matthes; M Wintzerith; C Schatz; A Wildeman; P Chambon
Journal:  EMBO J       Date:  1986-02       Impact factor: 11.598

10.  A transcriptional enhancer sequence of HTLV-I is responsible for trans-activation mediated by p40 chi HTLV-I.

Authors:  J Fujisawa; M Seiki; M Sato; M Yoshida
Journal:  EMBO J       Date:  1986-04       Impact factor: 11.598

View more
  108 in total

1.  Interaction of Gli2 with CREB protein on DNA elements in the long terminal repeat of human T-cell leukemia virus type 1 is responsible for transcriptional activation by tax protein.

Authors:  S Dan; A Tanimura; M Yoshida
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  Anchoring of CREB binding protein to the human T-cell leukemia virus type 1 promoter: a molecular mechanism of Tax transactivation.

Authors:  H A Giebler; J E Loring; K van Orden; M A Colgin; J E Garrus; K W Escudero; A Brauweiler; J K Nyborg
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

Review 3.  Mechanism of action of regulatory proteins encoded by complex retroviruses.

Authors:  B R Cullen
Journal:  Microbiol Rev       Date:  1992-09

4.  Characterization of the promoter region of the src family gene lyn and its trans activation by human T-cell leukemia virus type I-encoded p40tax.

Authors:  F Uchiumi; K Semba; Y Yamanashi; J Fujisawa; M Yoshida; K Inoue; K Toyoshima; T Yamamoto
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

5.  The indirect association of human T-cell leukemia virus tax protein with DNA results in transcriptional activation.

Authors:  J Fujisawa; M Toita; T Yoshimura; M Yoshida
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

6.  Studies of heterologous promoter trans-activation by the HTLV-II tax protein.

Authors:  J L Williams; A J Cann; T Leff; P Sassone-Corsi; I S Chen
Journal:  Nucleic Acids Res       Date:  1989-07-25       Impact factor: 16.971

7.  SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat.

Authors:  Y Takebe; M Seiki; J Fujisawa; P Hoy; K Yokota; K Arai; M Yoshida; N Arai
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

8.  Characterization of cellular factors that interact with the human T-cell leukemia virus type I p40x-responsive 21-base-pair sequence.

Authors:  K T Jeang; I Boros; J Brady; M Radonovich; G Khoury
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

9.  T-cell receptor/CD28 engagement when combined with prostaglandin E2 treatment leads to potent activation of human T-cell leukemia virus type 1.

Authors:  Nancy Dumais; Marie-Eve Paré; Simon Mercier; Salim Bounou; Susan J Marriot; Benoit Barbeau; Michel J Tremblay
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Selective infection of human T-lymphotropic virus type 1 (HTLV-1)-infected cells by chimeric human immunodeficiency viruses containing HTLV-1 tax response elements in the long terminal repeat.

Authors:  H C Lin; M Bodkin; R B Lal; A B Rabson
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.